Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

NCT00770822 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DEVICE: HIFU (Sonablate® 500)
DEVICE: Brachytherapy

Sponsor

SonaCare Medical